November 20, 2026

Healz.ai Introduces New Model for Consumer Health

Igor-Demishev

In a move that signals a dramatic shift in consumer health technology, Healz.ai has launched a platform where artificial intelligence not only answers medical questions, but can also pay licensed doctors to verify its own responses, all within minutes.

The new product came into the spotlight after Maria MacDonald, a tech-savvy mother, used Healz.ai to ask a routine health question. Seconds after receiving a detailed answer, the AI added an unexpected line:

“Health is serious, so I prefer a licensed doctor to double-check my answer. I’ll hire and pay a doctor to check me. It won’t take long.”

Ten minutes later, MacDonald received a confirmation from Dr. Jamie Sutcliffe, a doctor with a medical degree from King’s College London, verifying that the AI’s information was accurate. Sutcliffe has completed “dozens” of similar reviews for Healz.ai in recent weeks.

“Yes, I regularly verify AI-generated explanations,” Dr. Sutcliffe said. “Our role is strictly academic: to check the accuracy of the responses and add holistic information in case the AI misses something from the ‘big picture.’ The platform doesn’t allow us to communicate with users or provide private prescriptions. However, this format plays a major role in increasing overall health knowledge and serves as a source of verified information.”

Unlike telemedicine giants such as K Health (valued at $1.5B during its last $132M round in 2021) or Teladoc (which merged with Livongo for $18.5B in 2020), Healz.ai isn’t designed for consultations, booking appointments, or issuing prescriptions. Instead, it positions doctors as on-demand quality controllers, reviewing AI answers within minutes, with no direct patient interaction.

This distinction is increasingly important as global regulators evaluate how AI tools deliver medical information and where the line sits between education and clinical practice.

Founded by Igor Demishev and Alex Plat. Demishev previously co-founded Jiffy, which raised $35M for rapid-delivery operations in London. Plat built AI models for autonomous vehicles at Moove and developed clinical AI at the European Medical Center.

While users can choose to pay for a doctor’s review, the platform’s most surprising feature is that the AI itself manages its own verification budget. It independently decides when to hire a doctor to review its response, an experiment the founders describe as part of a broader philosophy.

“We want to create a global experiment in coexistence between AI and humans,” said Demishev. “To do that, they must be in equal positions: economically, in free will, and in decision-making. Even further, can AI be part of a doctors’ concilium? Will its voice count? Can AI run a hospital or a health system?”

Earlier this year, Anthropic tested this frontier by allowing Claude to autonomously run a business, an experiment that famously imploded. In health, experts warn the consequences of AI autonomy could be far more serious. As OpenAI CEO Sam Altman said: “I really do not want to entrust my medical fate to ChatGPT with no human doctor in the loop.”

Early adopters say the platform feels markedly different from generic AI chat tools.

“I’ve tried Healz.ai for a personal health discussion and found it promising,” said Alex Dang, Senior Advisor at McKinsey and former Senior Product Leader at Amazon. “It delivers personalization and human-in-the-loop input. This combination creates a better product and a stronger sales engine and moat.”

Alex Nikityuk, Founder & CEO of Maroo (YC ’21) and former Revolut leader, added: “This product is bold. It has the same energy I saw at Revolut. That product cut the pain of opening a bank account from weeks to minutes. Healz.ai is applying the same logic to healthtech. The real test is whether the founders can sustain that speed.”

In 2025, Sequoia led a $75M Series A for OpenEvidence at a $1B valuation, adding it to the year’s growing unicorn list. OpenEvidence focuses on clinician-grade medical search for doctors and health systems, including partnerships with the New England Journal of Medicine.

Healz.ai instead targets the mass consumer market, bringing verification-first medical information directly into people’s homes and mobile devices.

As regulatory pressures mount worldwide, the company’s “verified-by-default” model may hint at a new compliance standard for AI-driven health information.